Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-06-30

FDA Approved: BUPROPION HYDROCHLORIDE (XL) — Supplemental Application (ScieGen Pharmaceuticals,Inc.)

View source ↗

Summary

FDA approved a supplemental application to authorize the marketing of Bupropion Hydrochloride (XL) from ScieGen Pharmaceuticals, the extended-release formulatio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BUPROPION HYDROCHLORIDE XL (BUPROPION HYDROCHLORIDE)

Snippet

SUPPL AP for BUPROPION HYDROCHLORIDE (XL) (BUPROPION HYDROCHLORIDE)